Several studies have shown that mitochondrial UCP-2 gene is highly expressed in HER2 positive breast cancer patients and cell lines, and elevated UCP-2 expression has been linked to tumor progression, increased resistance to oxidative stress by reducing mitochondrial reactive oxygen species (ROS), and resistance to various anti-tumor drugs [11–13]. This evidence concerns the gene ERBB2 and neoplasm.